4.32
price down icon3.16%   -0.11
 
loading
Schlusskurs vom Vortag:
$4.43
Offen:
$4.26
24-Stunden-Volumen:
71,654
Relative Volume:
0.11
Marktkapitalisierung:
$469.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-299.80M
KGV:
-0.3564
EPS:
-12.1221
Netto-Cashflow:
$-217.49M
1W Leistung:
-16.86%
1M Leistung:
-30.58%
6M Leistung:
-0.92%
1J Leistung:
-50.23%
1-Tages-Spanne:
Value
$4.24
$4.44
1-Wochen-Bereich:
Value
$4.24
$5.19
52-Wochen-Spanne:
Value
$3.36
$8.885

Acelyrin Inc Stock (SLRN) Company Profile

Name
Firmenname
Acelyrin Inc
Name
Telefon
805-871-4300
Name
Adresse
4149 LIBERTY CANYON RD., AGOURA HILLS
Name
Mitarbeiter
130
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-13
Name
Neueste SEC-Einreichungen
Name
SLRN's Discussions on Twitter

Vergleichen Sie SLRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
SLRN 4.335 469.02M 0 -299.80M -217.49M -12.12
VRTX 445.82 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.34 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 589.04 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.89 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.89 24.49B 3.30B -501.07M 1.03B 11.54

Acelyrin Inc Stock (SLRN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-14 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-08 Hochstufung Wells Fargo Equal Weight → Overweight
2023-12-13 Eingeleitet Wells Fargo Equal Weight
2023-12-08 Eingeleitet Citigroup Neutral
2023-09-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-09-05 Eingeleitet H.C. Wainwright Buy
2023-05-30 Eingeleitet Jefferies Buy
2023-05-30 Eingeleitet Morgan Stanley Overweight
2023-05-30 Eingeleitet Piper Sandler Overweight
2023-05-30 Eingeleitet TD Cowen Outperform
Alle ansehen

Acelyrin Inc Aktie (SLRN) Neueste Nachrichten

pulisher
Nov 18, 2024

HC Wainwright Issues Positive Estimate for Acelyrin Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 15, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

TD Cowen maintains Buy rating on Acelyrin shares By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

Acelyrin discloses ValenzaBio acquisition financials - Investing.com India

Nov 15, 2024
pulisher
Nov 14, 2024

TD Cowen maintains Buy rating on Acelyrin shares - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

T. Rowe Price Investment Management, Inc. Reduces Stake in Acely - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Earnings call: Acelyrin focuses on TED treatment, eyes Phase 3 trials - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Acelyrin Inc (SLRN) Q3 2024 Earnings Call Highlights: Strategic Pipeline Refocus and Financial ... By GuruFocus - Investing.com Canada

Nov 14, 2024
pulisher
Nov 13, 2024

ACELYRIN, INC. Advances Key Drug Developments - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

ACELYRIN Reports $562M Cash Position, Advances Key Clinical Trials Amid Pipeline Focus | SLRN Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 08, 2024

(SLRN) Investment Analysis and Advice - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 07, 2024

Acelyrin (SLRN) Set to Announce Earnings on Wednesday - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

ACELYRIN, INC. to Report Third Quarter 2024 Financial Results and Corporate Update on November 13, 2024 - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

ACELYRIN Sets Q3 2024 Earnings Call: Immunology Pipeline Updates Coming Nov 13 | SLRN Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Acelyrin Inc Shares - GuruFocus.com

Nov 05, 2024
pulisher
Oct 30, 2024

10 Best IPO Stocks To Buy Heading into 2025 - Insider Monkey

Oct 30, 2024
pulisher
Oct 28, 2024

(SLRN) Proactive Strategies - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 28, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives $11.17 Consensus PT from Analysts - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Update - MarketBeat

Oct 27, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 4,163 Shares of Acelyrin, Inc. (NASDAQ:SLRN) - Defense World

Oct 20, 2024
pulisher
Oct 18, 2024

Acelyrin (NASDAQ:SLRN) Trading Down 6.9%What's Next? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

(SLRN) Trading Advice - Stock Traders Daily

Oct 18, 2024
pulisher
Oct 17, 2024

Acelyrin (NASDAQ:SLRN) Trading 4.8% Higher on Analyst Upgrade - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

SLRNACELYRIN, INC. Latest Stock News & Market Updates - StockTitan

Oct 17, 2024
pulisher
Oct 16, 2024

Wells Fargo & Company Boosts Acelyrin (NASDAQ:SLRN) Price Target to $15.00 - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease - The Manila Times

Oct 16, 2024
pulisher
Oct 14, 2024

Did Acelyrin Inc (SLRN) perform well in the last session? - US Post News

Oct 14, 2024
pulisher
Oct 11, 2024

Acelyrin (NASDAQ:SLRN) Stock Price Down 2.4%Should You Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 11, 2024

Acelyrin Inc (SLRN) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Oct 11, 2024
pulisher
Oct 10, 2024

Acelyrin (NASDAQ:SLRN) Shares Up 5.9%Still a Buy? - MarketBeat

Oct 10, 2024
pulisher
Oct 06, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Shares Sold by Point72 Asset Management L.P. - MarketBeat

Oct 06, 2024
pulisher
Oct 05, 2024

Millennium Management LLC Has $20.47 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 05, 2024
pulisher
Oct 04, 2024

Renaissance Technologies LLC Has $1.75 Million Stake in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

160,167 Shares in Acelyrin, Inc. (NASDAQ:SLRN) Bought by Susquehanna Fundamental Investments LLC - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Susquehanna Fundamental Investments LLC Takes Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Acelyrin, Inc. (NASDAQ:SLRN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Acelyrin Inc (SLRN) - Knox Daily

Oct 02, 2024
pulisher
Sep 29, 2024

Almitas Capital LLC Buys New Position in Acelyrin, Inc. (NASDAQ:SLRN) - MarketBeat

Sep 29, 2024
pulisher
Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares - Investing.com

Sep 25, 2024
pulisher
Sep 25, 2024

Piper Sandler maintains Overweight rating on Acelyrin shares By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 25, 2024

Acelyrin Inc [SLRN] Director makes an insider sale of 1 shares worth $7.0. - Knox Daily

Sep 25, 2024
pulisher
Sep 25, 2024

Top investors say Acelyrin Inc (SLRN) ticks everything they need - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Acelyrin Insider Sellers Miss The Bus As Stock Jumps 12% - Simply Wall St

Sep 25, 2024
pulisher
Sep 24, 2024

Can Acelyrin Inc Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle

Sep 24, 2024
pulisher
Sep 23, 2024

Acelyrin (NASDAQ:SLRN) Shares Down 5.4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

How did Acelyrin Inc (SLRN) fare last session? - US Post News

Sep 23, 2024
pulisher
Sep 20, 2024

Acelyrin: Straight Move To Phase 3 TED Studies Makes It Must Watch (NASDAQ:SLRN) - Seeking Alpha

Sep 20, 2024
pulisher
Sep 19, 2024

Acelyrin (NASDAQ:SLRN) Shares Gap Up to $4.60 - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Acelyrin stock spikes on upcoming presentation (NASDAQ:SLRN) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Acelyrin announces positive results from Phase 3 trial of izokibep - TipRanks

Sep 19, 2024

Finanzdaten der Acelyrin Inc-Aktie (SLRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Acelyrin Inc-Aktie (SLRN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Lin Shao-Lee
Chief Executive Officer
Apr 01 '24
Sale
6.63
9,961
66,024
1,577,374
Lin Shao-Lee
Chief Executive Officer
Feb 20 '24
Sale
7.60
15,701
119,403
1,587,335
Lin Shao-Lee
Chief Executive Officer
Jan 02 '24
Sale
7.41
10,691
79,188
1,603,036
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):